Evotec SE
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany. Show More...
-
Website https://www.evotec.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 6.79 EUR
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share EUR 0.03 0.06 0.02 -0.21 -0.05 0.12 0.2 0.16 0.56 0.25 0.27 Dividends EUR Payout Ratio % * Shares Mil 109.0 116.0 117.0 121.0 131.0 138.0 133.0 145.0 147.0 150.0 150.0 Book Value Per Share * EUR 2.62 3.07 3.24 Free Cash Flow Per Share * EUR 0.71 0.010 Return on Assets % 1.93 3.29 1.12 -11.23 -3.09 6.44 8.6 4.76 11.7 3.9 4.58 Financial Leverage (Average) 1.45 1.48 1.48 1.43 1.42 1.56 1.65 2.02 1.82 2.48 2.42 Return on Equity % 2.68 4.83 1.65 -16.33 -4.4 9.61 13.82 8.92 22.3 8.45 10.09 Return on Invested Capital % 2.78 5.16 1.95 -13.9 -3.37 8.94 12.47 6.45 16.12 5.61 6.35 Interest Coverage 5.47 3.83 -1.7 -11.65 -2.18 8.24 22.63 21.88 28.79 8.59 7.35 Current Ratio 2.64 1.95 2.6 3.15 3.79 2.96 2.31 0.73 1.27 2.62 2.51 Quick Ratio 2.45 1.73 2.38 2.98 3.48 2.77 2.13 0.6 1.07 2.33 2.21 Debt/Equity 0.03 0.02 0.03 0.05 0.05 0.03 0.06 0.14 0.93 0.89